“Tirzepatide Across the Cardiovascular Continuum From HFpEF to Cardiorenal Protection With a Dual GLP-1 GIP Agonist”. 2026. Diabzen 4 (21): 42-43. https://thediabzen.com/index.php/d/article/view/64.